FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205398001> ?p ?o ?g. }

• W3205398001 endingPage "S124" @default.
• W3205398001 startingPage "S123" @default.
• W3205398001 abstract "Study Objective To compare local management of women diagnosed with atypical endometrial hyperplasia (AH) against RCOG Greentop Guideline No. 67 “Management of endometrial hyperplasia,” with specific emphasis on conservative treatment. Design An existing database of patients with endometrial pathology from 2012 to 2019 was used to identify 118 cases of AH. Patient demographics, management, and follow up were interrogated. Setting NHS Lanarkshire, Scotland (population 655,000). Patients or Participants Patient age ranged from 26-83 years with 50% over the age of fifty. 75% of patients were postmenopausal and 90% were overweight (BMI >25). Interventions Seventy-eight women (66%) had immediate hysterectomy. Thirty-five women (30%) underwent conservative management and five (4%) were lost to follow up. Conservative treatment comprised of levonorgestrel-releasing intrauterine system (LNG-IUS) (67%), oral progestogens (18%), GnRH analogues (9%), weight loss alone or no management (6%). Measurements and Main Results Follow up biopsy results in the conservative treatment group showed regression in fourteen patients (67%), persistence in five (23%) and progression to endometrial cancer in two (10%). Low rates of progression (12% overall) and persistence were observed overtime alongside continued regression rates. Eight women (23%) managed conservatively subsequently progressed to hysterectomy. Four of which required surgery due to the development of endometrial carcinoma. Conclusion Local management is consistent with current RCOG guidelines with more than half of women proceeding immediately to hysterectomy. The majority of patients managed conservatively had the LNG-IUS, consistent with guidelines. Follow up was appropriate in terms of monitoring and tissue sampling with four cases of endometrial cancer detected. This emphasises the importance of regular monitoring. Over 90% had an elevated BMI, a known risk factor for developing AH. Literature supports weight loss in improving regression rates in this demographic. In some cases, an initial conservative approach may allow peri-operative optimisation and risk factor modification which has a role in improving surgical outcomes. To compare local management of women diagnosed with atypical endometrial hyperplasia (AH) against RCOG Greentop Guideline No. 67 “Management of endometrial hyperplasia,” with specific emphasis on conservative treatment. An existing database of patients with endometrial pathology from 2012 to 2019 was used to identify 118 cases of AH. Patient demographics, management, and follow up were interrogated. NHS Lanarkshire, Scotland (population 655,000). Patient age ranged from 26-83 years with 50% over the age of fifty. 75% of patients were postmenopausal and 90% were overweight (BMI >25). Seventy-eight women (66%) had immediate hysterectomy. Thirty-five women (30%) underwent conservative management and five (4%) were lost to follow up. Conservative treatment comprised of levonorgestrel-releasing intrauterine system (LNG-IUS) (67%), oral progestogens (18%), GnRH analogues (9%), weight loss alone or no management (6%). Follow up biopsy results in the conservative treatment group showed regression in fourteen patients (67%), persistence in five (23%) and progression to endometrial cancer in two (10%). Low rates of progression (12% overall) and persistence were observed overtime alongside continued regression rates. Eight women (23%) managed conservatively subsequently progressed to hysterectomy. Four of which required surgery due to the development of endometrial carcinoma. Local management is consistent with current RCOG guidelines with more than half of women proceeding immediately to hysterectomy. The majority of patients managed conservatively had the LNG-IUS, consistent with guidelines. Follow up was appropriate in terms of monitoring and tissue sampling with four cases of endometrial cancer detected. This emphasises the importance of regular monitoring." @default.
• W3205398001 created "2021-10-25" @default.
• W3205398001 creator A5010456877 @default.
• W3205398001 creator A5058927081 @default.
• W3205398001 creator A5090553630 @default.
• W3205398001 date "2021-11-01" @default.
• W3205398001 modified "2023-09-26" @default.
• W3205398001 title "Management of Atypical Endometrial Hyperplasia with a Focus on Conservative Treatment" @default.
• W3205398001 doi "https://doi.org/10.1016/j.jmig.2021.09.207" @default.
• W3205398001 hasPublicationYear "2021" @default.
• W3205398001 type Work @default.
• W3205398001 sameAs 3205398001 @default.
• W3205398001 citedByCount "0" @default.
• W3205398001 crossrefType "journal-article" @default.
• W3205398001 hasAuthorship W3205398001A5010456877 @default.
• W3205398001 hasAuthorship W3205398001A5058927081 @default.
• W3205398001 hasAuthorship W3205398001A5090553630 @default.
• W3205398001 hasConcept C121608353 @default.
• W3205398001 hasConcept C126322002 @default.
• W3205398001 hasConcept C131872663 @default.
• W3205398001 hasConcept C141071460 @default.
• W3205398001 hasConcept C142724271 @default.
• W3205398001 hasConcept C2777088508 @default.
• W3205398001 hasConcept C2777689261 @default.
• W3205398001 hasConcept C2779494336 @default.
• W3205398001 hasConcept C2779742232 @default.
• W3205398001 hasConcept C2780182762 @default.
• W3205398001 hasConcept C2780904754 @default.
• W3205398001 hasConcept C2781283455 @default.
• W3205398001 hasConcept C2908647359 @default.
• W3205398001 hasConcept C29456083 @default.
• W3205398001 hasConcept C71924100 @default.
• W3205398001 hasConcept C99454951 @default.
• W3205398001 hasConceptScore W3205398001C121608353 @default.
• W3205398001 hasConceptScore W3205398001C126322002 @default.
• W3205398001 hasConceptScore W3205398001C131872663 @default.
• W3205398001 hasConceptScore W3205398001C141071460 @default.
• W3205398001 hasConceptScore W3205398001C142724271 @default.
• W3205398001 hasConceptScore W3205398001C2777088508 @default.
• W3205398001 hasConceptScore W3205398001C2777689261 @default.
• W3205398001 hasConceptScore W3205398001C2779494336 @default.
• W3205398001 hasConceptScore W3205398001C2779742232 @default.
• W3205398001 hasConceptScore W3205398001C2780182762 @default.
• W3205398001 hasConceptScore W3205398001C2780904754 @default.
• W3205398001 hasConceptScore W3205398001C2781283455 @default.
• W3205398001 hasConceptScore W3205398001C2908647359 @default.
• W3205398001 hasConceptScore W3205398001C29456083 @default.
• W3205398001 hasConceptScore W3205398001C71924100 @default.
• W3205398001 hasConceptScore W3205398001C99454951 @default.
• W3205398001 hasIssue "11" @default.
• W3205398001 hasLocation W32053980011 @default.
• W3205398001 hasOpenAccess W3205398001 @default.
• W3205398001 hasPrimaryLocation W32053980011 @default.
• W3205398001 hasRelatedWork W1993046995 @default.
• W3205398001 hasRelatedWork W2092399942 @default.
• W3205398001 hasRelatedWork W2178250839 @default.
• W3205398001 hasRelatedWork W2395547044 @default.
• W3205398001 hasRelatedWork W2416695321 @default.
• W3205398001 hasRelatedWork W2557495611 @default.
• W3205398001 hasRelatedWork W3006859148 @default.
• W3205398001 hasRelatedWork W3044449251 @default.
• W3205398001 hasRelatedWork W312014534 @default.
• W3205398001 hasRelatedWork W4312999812 @default.
• W3205398001 hasVolume "28" @default.
• W3205398001 isParatext "false" @default.
• W3205398001 isRetracted "false" @default.
• W3205398001 magId "3205398001" @default.
• W3205398001 workType "article" @default.